EcoR1 Capital »

First Tracks Biotherapeutics shares owned by EcoR1 Capital

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $64M 3.2M 20.12

More positions owned by EcoR1 Capital

Zymeworks Del (ZYME)
Anaptysbio Inc Common (ANAB)
Aktis Oncology (AKTS)
Cg Oncology (CGON)
Eton Pharmaceuticals (ETON)
Crispr Therapeutics Namen Akt (CRSP)
Oric Pharmaceuticals (ORIC)
First Tracks Biotherapeutics Ord Shs Added (TRAX)
Lakefront Biotherapeutics Nv Spon Adr
Neurogene (NGNE)
Stoke Therapeutics (STOK)
Fulcrum Therapeutics (FULC)
Legend Biotech Corp Sponsored Ads (LEGN)
Bridgebio Oncology Therapeut Com New (BBOT)
Mbx Biosciences (MBX)

View all positions for EcoR1 Capital

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Bank of America Corporation
Sofinnova Ventures

View all funds holding First Tracks Biotherapeutics